Surgeon removes cancer from 1,500 miles away using robot. A real patient in Gibraltar shows how remote robotic surgery may reshape medicine.
To address this need, HMP Global today announced the launch of the Radiopharmaceutical Education Institute (RPEI), a new clinician-focused educational platform from Oncology Learning Network (OLN), ...
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit desired safety and ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...
Recent health updates highlight the FDA's approval of Lantheus' new prostate cancer imaging agent to enhance production ...
The FDA approved a new Lantheus prostate cancer imaging agent. South Carolina's measles cases rise. Medtronic's MiniMed shares drop in Nasdaq debut. A French probe exonerates Nestle in a baby death ...
In 2025, adults aged 25-34 FAIR Health Consumer, while adults 65 and older (the largest user group in 2024) remained a high proportion of users. FAIR Health Consumer (fairhealthconsumer.org) is FAIR ...
Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...
New AI tool from UC San Diego and collaborators precisely maps the urethra on MRI to make prostate cancer radiation safer and reduce urinary side effects. Running on SDSC’s Expanse supercomputer, the ...